Rimekor 20 mg

Rimekor - a drug for the treatment of cardiovascular diseases.

Pharmacological action

Rimekor prevents hypoxia has antiischemic effect, a positive effect on brain neurons and cardiomyocytes, the heart muscle contractility support, restores the level of potassium ions in the cells.

Application Rimekora angina reduces the frequency of attacks, reduce the consumption of nitrates, increase physical endurance, to eliminate pressure differences. Patients suffering from angina and take Rimekor note that they reduced tinnitus and dizziness, improve hearing.

In addition, a good effect is observed when using the drug in the vascular pathology of the eye - under its influence is reduced activity of the retina.

The active ingredient of the drug - trimetazidine dihydrochloride.

Product form

Rimekor release tablets.

Indications Rimekora

Rimekor of instruction prescribed for dizziness caused by vascular pathology, cochle-vestibular disorders such as hearing loss and tinnitus. The drug is used in coronary heart disease for the prevention stenokardicheskie attacks, but take into account that cupping do not use it.

Instructions Rimekora: how to use

The drug is taken in a dosage of 80-180 mg per day in two or three steps. The duration of treatment is determined individually in each case.

Take the tablets with meals is recommended.

Side effects

Due to the application may begin Rimekora rush of blood to the face, nausea, gastralgia, vomiting, pruritus, dyspepsia, abdominal pain, diarrhea, hypotension. In some cases, during treatment begins palpitations, a headache, dizziness, tremor begins.

These side effects are in most cases run their own after stopping the drug, but after their appearance should definitely see a doctor.

Not recorded data on overdose trimetazidine.

 Rimekor pills


Rimekor should not be prescribed to children under 18 l., In patients with severe hepatic impairment, hypersensitive to trimetazidine.

In chronic renal failure to take the drug is also not recommended (creatinine clearance less than 15 ml / min).

Pregnant women, breastfeeding women should not be prescribed the drug.

Patients with coronary heart disease should be aware that due to the use Rimekora they require a lower dose of nitrates.

The attention and speed of psychomotor reactions trimetasidine not affected.